Day: August 12, 2020

Pursuant to the article L. 233-8 II of the French “Code de Commerce” and the article 223-16 of the French stock-market authorities (Autorité des Marchés Financiers, or “AMF”) General Regulation, Innate Pharma SA (the “Company” – Euronext Paris: FR0010331421 – IPH; Nasdaq: IPHA) releases its total number of shares outstanding as well as its voting rights as at August 1, 2020:(1) The total number of theoretical voting rights (or “gross” voting rights) is used as the basis for calculating the crossing of shareholding thresholds. In accordance with Article 223-11 of the AMF General Regulation, this number is calculated on the basis of all shares to which voting rights are attached, including shares whose voting rights have been suspended. The total number of theoretical voting rights includes (i) voting rights attached to AGAP 2016...

Conformément aux articles L. 233-8 II du Code de Commerce et 223-16 du règlement général de l’Autorité des marchés financiers (l’« AMF »), Innate Pharma SA (la « Société » – Euronext Paris : FR0010331421 – IPH ; Nasdaq : IPHA) publie le nombre d’actions composant son capital social ainsi que le nombre de droits de vote associés au 1er août 2020 :                                                                                                 (1) Le nombre de droits de vote théoriques (ou droits de vote « bruts ») sert de base de calcul pour les franchissements de seuils. Conformément à l’article 223-11 du Règlement Général de l’AMF, ce nombre est calculé sur la base de l’ensemble des actions auxquelles sont attachés des droits de vote, y compris les actions privées de droit de vote. Le nombre de droits de vote théoriques comprend...

Awilco Drilling PLC reported contract revenue of USD 6.4 million (nil Q1), EBITDA USD 1.5 million loss (USD 7.4 million loss in Q1) and a net loss of USD 4.6 million (USD 9.4 million loss in Q1).Revenue efficiency was 100% during the quarter (nil in Q1).Operational uptime was 100% during the quarter (nil in Q1).Contract utilisation was 34.1% during the quarter (nil in Q1).Contract backlog at the end of Q2 was approximately USD 19.4 million (USD 13.8 million Q1).Please see attached for the Q2 2020 report.A digital presentation will be held today, 12 August 2020, at 13:00 UK time (14:00pm CET / 08:00 EST). The presentation will be available for download on the Investor Relations section (go to “Press Releases”) at www.awilcodrilling.com prior to the meeting. There will be a Q&A session after the presentation.To join the...

ABN AMRO reports net loss of EUR 5 million for Q2 2020 Breakeven net result (EUR 5 million negative) reflects high impairmentsContinued engagement with clients to support them through Covid-19Good operational performance; net interest income under pressure from low interest ratesCosts continue to benefit from cost-saving programmesRobust capital position, with a CET1 ratio of 17.3% (Basel III) and around 14% (Basel IV)Bank to focus on Netherlands and Northwest EuropeSignificant risk reduction in global sectors is expected to be capital accretive over timeRobert Swaak, CEO, comments:‘When I started as CEO of ABN AMRO I set four priorities: navigate the bank through the Covid-19 crisis, review the strategy, focus on our licence to operate, and further enhance the bank’s culture. We have made progress in all areas, including the strategy...

ABN AMRO rapporteert nettoverlies van EUR 5 miljoen over Q2 2020Break-even nettoresultaat (EUR 5 miljoen negatief) weerspiegelt hoge kredietvoorzieningenVoortdurende betrokkenheid bij klanten om hen bij te staan gedurende Covid-19Goed operationeel resultaat; netto rentebaten onder druk door lage renteKosten blijven dalen dankzij kostenbeheersingRobuuste kapitaalpositie; Basel III CET1 ratio van 17,3% en Basel IV CET1 ratio circa 14%Bank zal zich focussen op Nederland en Noordwest EuropaSignificante risicoreductie in wereldwijde sectoren zal naar verwachting in de komende jaren de kapitaalpositie versterkenRobert Swaak, CEO:‘Toen ik als CEO van ABN AMRO begon, heb ik vier prioriteiten gesteld: de bank door de Covid-19 crisis loodsen, de strategie onder de loep nemen, ons focussen op onze licence-to-operate, en de cultuur van de bank verder...

In the second quarter of 2020, Hexagon Group generated NOK 683 (882) million in revenues and recorded an operating profit before depreciation (EBITDA) of NOK 19 (62) million. Profitability was reduced by the impacts of the global pandemic and resulting macro factors, particularly in Agility Fuel Solutions and Hexagon Mobile Pipeline businesses. Hexagon Ragasco experienced a strong quarter.The first half of 2020 provided revenues of NOK 1,508 (1,704) million and an operating profit before depreciation (EBITDA) of NOK 56 (212) million. The 2019 comparative EBITDA included overall positive impacts related to the Agility Fuel Solutions transaction of NOK 62 million, in the first quarter of that year.The financial impacts of COVID-19 were most apparent in the second quarter, especially impacting transit bus demand in North America and Europe...

Financial results for the first half of 2020Surge in orders; order entry increased to CHF 374.0 million (H1 2019: CHF 310.6 million)Increase of 24.3% in local currencies or 20.4% in Swiss francsSales of CHF 310.0 million (H1 2019: CHF 296.1 million)Growth of 8.0% in local currencies or 4.7% in Swiss francsBoth business segments contributing to growth; pronounced headwinds and tailwinds from the coronavirus pandemicReported operating profit before depreciation and amortization (EBITDA) of CHF 60.2 million (H1 2019: CHF 49.3 million)Reported EBITDA margin of 19.4% (H1 2019: 16.6%; including non-recurring costs of around 90 basis points)Reported net profit of CHF 36.0 million (H1 2019: CHF 25.3 million)Earnings per share increased by 41.1% to CHF 3.02 (H1 2019: CHF 2.14)Outlook for full-year sales and reported EBITDA margin raisedOperating...

Finanzresultate erstes Halbjahr 2020Auftragseingang mit starkem Anstieg auf CHF 374.0 Mio. (H1 2019: CHF 310.6 Mio.)Zunahme von 24.3% in Lokalwährungen bzw. 20.4% in Schweizer FrankenUmsatz von CHF 310.0 Mio. (H1 2019: CHF 296.1 Mio.)Wachstum von 8.0% in Lokalwährungen bzw. 4.7% in Schweizer FrankenBeide Geschäftssegmente tragen zum Wachstum bei; erhebliche negative und positive Effekte aufgrund der Coronavirus-PandemieAusgewiesenes Betriebsergebnis vor Abschreibungen (EBITDA) von CHF 60.2 Mio. (H1 2019: CHF 49.3 Mio.)Ausgewiesene EBITDA-Marge von 19.4% (H1 2019: 16.6%; einschliesslich einmalig auftretender Kosten von etwa 90 Basispunkten)Ausgewiesener Gewinn von CHF 36.0 Mio. (H1 2019: CHF 25.3 Mio.)Der Gewinn pro Aktie steigerte sich um 41.1% auf CHF 3.02 (H1 2019: CHF 2.14)Ausblick für Gesamtjahresumsatz und ausgewiesene EBITDA-Marge...

MENLO PARK, Calif., Aug. 11, 2020 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq: PACB) (“Pacific Biosciences” or the “Company”) today announced that it has priced its previously announced underwritten public offering of 19,430,000 shares of its common stock at a price to the public of $4.47 per share.  The offering is expected to close on or about August 14, 2020 subject to satisfaction of customary closing conditions.  Pacific Biosciences also granted the underwriters a 30-day option to purchase up to an additional 2,914,500 shares of its common stock at the public offering price, less underwriting discounts and commissions.  Before deducting the underwriting discount and estimated offering expenses payable by the Company, the Company expects to receive gross proceeds of approximately $86.9 million, assuming...

HAMILTON, Bermuda, Aug. 11, 2020 (GLOBE NEWSWIRE) — Hermitage Offshore Services Ltd. and 28 of its subsidiaries including all its vessel-owning subsidiaries (collectively, the “Company”) announced today that they have filed voluntary petitions for reorganization under Chapter 11 of the Bankruptcy Code in the United States Bankruptcy Court for the Southern District of New York.The Company took this action following a prolonged slump in global oil prices, driven in part by the global coronavirus pandemic, and its effect on the Company’s business.  While the Company would have preferred to complete its financial restructuring out of court, it was unable to reach a consensual agreement with its lenders, which made filing Chapter 11 necessary to provide a single forum for all continuing conversations with its lenders. The Company anticipates...